Cadila Healthcare Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cadila Healthcare Ltd with three other
companies in this sector in India:
Piramal Enterprises Limited
sales of 85.04 billion Indian Rupees [US$1.34 billion]
of which 47%
Glenmark Pharmaceuticals Ltd
(91.86 billion Indian Rupees [US$1.45 billion]
of which 100%
was Pharmaceuticals), and
Jubilant Life Sciences Limited
(58.61 billion Indian Rupees [US$922.59 million]
of which 53%
Cadila Healthcare Ltd reported sales of 94.30 billion Indian Rupees (US$1.48 billion)
March of 2017.
decrease of 4.1%
versus 2016, when the company's sales were 98.38 billion Indian Rupees.